Dietrich John Pauls

Insider Reports History

Entity
Individual
Location
2 Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dietrich John Pauls:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. President and CEO, Director Voting Common Shares, no par value per share 68.6K $192K $2.80 Jun 1, 2024 Direct
DiaMedica Therapeutics Inc. President and CEO, Director Stock Option (right to buy) 300K Jun 1, 2024 Direct

Insider Reports Filed by Dietrich John Pauls

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 President and CEO, Director
DMAC DiaMedica Therapeutics Inc. Jun 23, 2023 1 $50K 4 Jun 26, 2023 President and CEO, Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 President and CEO, Director
DMAC DiaMedica Therapeutics Inc. Nov 16, 2022 1 $24.2K 4 Nov 16, 2022 President and CEO, Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 President and CEO, Director
DMAC DiaMedica Therapeutics Inc. Aug 16, 2021 1 $15.7K 4 Aug 16, 2021 President and CEO, Director
DMAC DiaMedica Therapeutics Inc. Jul 28, 2021 1 $0 4 Jul 29, 2021 President and CEO, Director